The drug development process: from target discovery to the clinic

被引:2
|
作者
Newell, DR [1 ]
机构
[1] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
关键词
analogue development; cytotoxic drugs; imatinib; targeted therapy; trastuzumab;
D O I
10.7861/clinmedicine.3-4-323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:323 / 326
页数:4
相关论文
共 50 条
  • [32] Fragment-based drug discovery: From crystal to clinic
    Patel, Joe
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C37 - C37
  • [33] Fragment-based drug discovery: From crystal to clinic
    Howard, Steven
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 559 - 559
  • [34] From discovery to targeted drug development
    Ullrich, A.
    [J]. FEBS JOURNAL, 2012, 279 : 38 - 38
  • [35] Developmental Therapeutics Program at the NCI: molecular target and drug discovery process
    Monga, M
    Sausville, EA
    [J]. LEUKEMIA, 2002, 16 (04) : 520 - 526
  • [36] Developmental Therapeutics Program at the NCI: molecular target and drug discovery process
    M Monga
    EA Sausville
    [J]. Leukemia, 2002, 16 : 520 - 526
  • [37] Drug discovery strategies: Technologies to accelerate translation from target to drug
    Workman, P
    [J]. JOURNAL OF CHEMOTHERAPY, 2004, 16 : 13 - 15
  • [38] Drug discovery and development: lessons from an undeveloped drug
    Gordi, Toufigh
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (02) : 157 - 162
  • [39] Drug development: From experimental models to the clinic
    Viveros, O. H.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 7 - 7
  • [40] Development of Systematic Target Drug Prioritization Process in Korea
    Chung, Sooyoun
    Ahn, So-Hyeon
    Kim, Sujin
    Cho, Joo Young
    Kim, Je Yon
    Choi, Yeun Jung
    Park, Byung-Joo
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 88 - 88